LEARNING OBJECTIVES
- Compare and contrast lipid injectable emulsions used in pediatric and neonatal patients.
- Describe the literature regarding the use of newer lipid injectable emulsions utilized in pediatric and neonatal patients.
- Determine biochemical and clinical essential fatty acid deficiency in pediatric and neonatal patients receiving newer lipid injectable emulsions.
PRESENTERS AND TOPICS
Use of Lipid Injectable Emulsions in Pediatric and Neonatal Patients: Similar but Different
M. Petrea Cober, PharmD, BCNSP, BCPPS, FASPEN, Professor of Pharmacy Practice; Director of Workforce Development, Office of Student Success; Director of Professional Development, Office of Education, Northeast Ohio Medical University, College of Pharmacy, Rootstown, OH
What We Know About Newer Lipid Injectable Emulsions in Pediatric and Neonatal Patients
Kara Calkins, MD, MS, Associate Professor, Neonatology, University of California Los Angeles, Los Angeles, CA
Essential Fatty Acid Deficiency: Facts vs. Misunderstandings
Kathleen Gura, PharmD, BCNSP, FASHP, FPPA, FASPEN, FMSHP, Pharmacy Clinical Research Program Manager, Boston Children’s Hospital, Boston, MA
Moderator
M. Petrea Cober, PharmD, BCNSP, BCPPS, FASPEN
CE Credit: 1.5 hours
Level: Advanced
UAN: JA0002345-0000-24-047-L99-P
 |
This session will be reviewed for BCNSP-approved recertification credit through Purdue University College of Pharmacy
|